1
results found
Background: The objective of Phase I/II dose-finding design is to determine the Optimal Biological Dose(OBD) that is acceptably safe and demonstrates sufficient anti-tumor activity by maximizing a pre...
Utility
Adaptive penalties
Toxicity-efficacy
Dose-optimization trial
SinoXiv